|
Market Closed -
Australian S.E.
09:10:22 23/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2550 AUD | -3.77% |
|
-17.74% | -36.25% |
| 10-05 | Alterity Therapeutics Limited Presents New Analyses of Ath434 Phase 2 Data in Multiple System Atrophy | CI |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
Company Valuation: Alterity Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21.56 | 11.37 | 14 | 59.84 | 86.52 | 41.09 | - | - |
| Change | - | -47.27% | 23.14% | 327.48% | 44.59% | -52.51% | - | - |
| Enterprise Value (EV) 1 | 21.56 | 11.37 | 9.172 | 38.2 | 59.75 | 31.14 | 4.156 | 35.38 |
| Change | - | -47.27% | -19.31% | 316.5% | 56.4% | -47.89% | -86.65% | 751.28% |
| P/E | - | - | - | - | -5.17x | -2.49x | -0.23x | -3.19x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | 0.32x | -0x | 0x |
| Capitalization / Revenue | 6.11x | 4.45x | 4.81x | 11.3x | 22.6x | 37.9x | 21x | 17x |
| EV / Revenue | 6.11x | 4.45x | 3.15x | 7.24x | 15.6x | 28.7x | 2.13x | 14.6x |
| EV / EBITDA | - | - | -0.71x | -4.68x | -3.33x | -1.29x | -0.18x | -1.76x |
| EV / EBIT | -2.07x | -1.22x | -0.71x | -4.87x | -3.33x | -1.16x | -0.13x | -1.09x |
| EV / FCF | -2.53x | - | -1.07x | -5.11x | -3.7x | -1.45x | -0.2x | -1.96x |
| FCF Yield | -39.6% | - | -93.4% | -19.6% | -27% | -68.9% | -507% | -51% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | - | - | -0.1112 | -0.1025 | -1.1 | -0.08 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3.528 | 2.554 | 2.909 | 5.278 | 3.832 | 1.084 | 1.954 | 2.422 |
| EBITDA 1 | - | - | -12.95 | -8.155 | -17.94 | -24.15 | -23.12 | -20.13 |
| EBIT 1 | -10.42 | -9.321 | -12.97 | -7.839 | -17.94 | -26.92 | -30.84 | -32.51 |
| Net income 1 | -8.843 | -8.966 | -12.97 | -7.927 | -16.83 | -27.31 | -30.69 | -31.54 |
| Net Debt 1 | - | - | -4.826 | -21.64 | -26.77 | -9.953 | -36.93 | -5.708 |
| Reference price 3 | 0.6500 | 0.3500 | 0.2000 | 0.5000 | 0.5750 | 0.2550 | 0.2550 | 0.2550 |
| Nbr of stocks (in thousands) | 48,137 | 48,798 | 104,902 | 182,547 | 217,509 | 229,101 | - | - |
| Announcement Date | 31/08/22 | 31/08/23 | 29/08/24 | 28/08/25 | 28/08/26 | - | - | - |
1AUD in Million2USD in Million3AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.49x | 28.73x | -1.29x | - | 41.09M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 7.93x | 26.43x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| Average | 23.84x | 26.68x | 14.00x | 0.32% | 38.32B | |
| Weighted average by Cap. | 26.72x | 25.32x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATH Stock
- Valuation Alterity Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
